IGM Biosciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IGMS research report →
About the company
IGM Biosciences, Inc. operates as a biotechnology firm dedicated to advancing Immunoglobulin M (IgM) antibodies. These novel therapeutic agents are being developed for a broad spectrum of conditions, including various cancers, infectious ailments, and autoimmune and inflammatory disorders.
- CEO
- Mary Beth Harler
- IPO
- 2019
- Employees
- 149
- HQ
- Mountain View, CA, US
Price Chart
- Market Cap
- $77.50M
- P/E
- 1.75
- P/S
- 0.54
- P/B
- 0.77
- EV/EBITDA
- 0.69
- Div Yield
- 0.00%
- Gross Margin
- 99.69%
- Op Margin
- 52.40%
- Net Margin
- 31.01%
- ROE
- 87.95%
- ROIC
- 74.82%
- Revenue
- $2.68M · 25.77%
- Net Income
- $-195,795,000 · 20.54%
- EPS
- $-3.24 · 31.21%
- Op Income
- $-208,580,000
- FCF YoY
- 22.37%
- 52W High
- $22.50
- 52W Low
- $0.92
- 50D MA
- $1.27
- 200D MA
- $3.58
- Beta
- 0.59
- Avg Volume
- 634.44K
Get TickerSpark's AI analysis on IGMS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 14, 25 | BAKER BROS. ADVISORS LP | other | 3,763,362 |
| Aug 14, 25 | BAKER BROS. ADVISORS LP | other | 9,886,217 |
| Aug 14, 25 | Redmile Group, LLC | sell | 2,964,843 |
| Aug 14, 25 | Redmile Group, LLC | sell | 7,199,325 |
| Aug 14, 25 | Redmile Group, LLC | sell | 667,666 |
| Aug 14, 25 | Hambleton Julie | sell | 2,000 |
| Aug 14, 25 | Lee Michael Stewart | sell | 12,712 |
| Aug 14, 25 | Topsoe Holding A/S | sell | 5,044,295 |
| Aug 14, 25 | Topsoe Holding A/S | sell | 10,400,564 |
| Aug 14, 25 | Topsoe Jakob Haldor | sell | 5,044,295 |
Our IGMS coverage
Recent articles, reports, and earnings notes.
No research on IGMS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IGMS report →Similar companies
Peers in the same neighborhood.